A research agenda for economic evaluation of substance abuse services

Journal of Substance Abuse Treatment

Volumn 29, Issue 2, 2005, Pages 125-137

  French, Michael T ^a,b   Drummond, Michael ^c  

^a University of Miami   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Addiction services research; Economic evaluation; Substance abuse

Indexed keywords

COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; ECONOMIC ASPECT; ECONOMICS; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH INSURANCE; HEALTH PROGRAM; HEALTH SERVICE; MEDICAL DECISION MAKING; MEDICAL RESEARCH; METHODOLOGY; PRIORITY JOURNAL; RESOURCE ALLOCATION; REVIEW; SUBSTANCE ABUSE;

EID: 28644441520     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2005.05.009     Document Type: Article

References (77)

1. D.W. Anderson, B.J. Bowland, W.S. Cartwright, and G. Bassin Service-level costing of drug abuse treatment Journal of Substance Abuse Treatment 13 1998 201 211
2. P.G. Barnett The cost-effectiveness of methadone maintenance as a health care intervention Addiction 94 1999 479 488
3. P.G. Barnett, G.S. Zaric, and M.L. Brandeau The cost-effectiveness of buprenorphine maintenance therapy for opiate addiction in the U.S. Addiction 96 2001 1267 1278
4. S. Belenko The challenges of conducting research in drug treatment court settings Substance Use & Misuse 37 2002 1635 1664
5. J. Bjørnera, and H. Keiding Cost effectiveness with multiple outcomes Health Economics 13 2004 1181 1190
6. N.N. Borisova, and A.C. Goodman Measuring the value of time for methadone maintenance clients: Willingness to pay, willingness to accept, and the wage rate Health Economics 12 2003 323 334
7. B.B. Brodey, C.S. Rosen, I.S. Brodey, B.M. Sheetz, R.R. Steinfeld, and D.R. Gastfriend Validation of the Addiction Severity Index (ASI) for the internet and automated telephone self-report administration Journal of Substance Abuse Treatment 25 2004 253 259
8. F. Byrne, R. Schauffler, L. Lightman, M. Finigan, and S. Carey California drug courts: A methodology for determining costs and avoided costs Journal of Psychoactive Drugs 2 2004 147 156 (Suppl.)
9. K. Claxton, and J. Posnett An economic approach to clinical trial design and research priority-setting Health Economics 5 1996 513 524
10. C. Dismuke, M.T. French, H.J. Salomé, C. Scott, M. Foss, and M.L. Dennis Out of touch or on the money: Do the clinical objectives of addiction treatment coincide with economic evaluation results Journal of Substance Abuse Treatment 27 2004 253 263
11. R.E. Drake, H.H. Goldman, S. Leff, A.F. Lehman, L. Dixon, and K.T. Mueser Implementing evidence based practices in routine mental health service settings Psychiatric Services 52 2001 179 182
12. M.F. Drummond, B.J. O'Brien, G.L. Stoddart, and G.W. Torrance Methods for the economic evaluation of health care programmes 2nd ed. 1997 Oxford University Press Oxford
13. M.F. Drummond, A. Manca, and M. Sculpher Increasing the generaliability of economic evaluations: Recommendations for the design, analysis and reporting of studies International Journal of Technology Assessment in Health Care 21 2 2005 165 171
14. M.F. Drummond, M.J. Sculpher, G.W. Torrance, B.J. O'Brien, and D.L. Stoddart Methods for the economic evaluation of health care programmes 3rd ed. 2005 Oxford Medical Publications Oxford
15. M.F. Fleming, M.P. Mundt, M.T. French, L.B. Manwell, E.A. Stauffacher, and K.L. Barry Benefit-cost analysis of brief physician advice with problem drinkers in primary care settings Medical Care 38 2000 7 18
16. M.F. Fleming, M.P. Mundt, M.T. French, L.B. Manwell, E.A. Stauffacher, and K.L. Barry Brief physician advice for problem drinkers: Long-term efficacy and benefit-cost analysis Alcoholism, Clinical and Experimental Research 26 2002 36 43
17. R.G. Frank, and T.G. McGuire Savings from a Medicaid carve-out for mental health and substance abuse services in Massachusetts Psychiatric Services 48 1997 1147 1152
18. M.T. French Economic evaluation of alcohol treatment services Evaluation and Program Planning 23 2000 27 39
19. M.T. French, L.J. Dunlap, G.A. Zarkin, K.A. McGeary, and A.T. McLellan A structured instrument for estimating the economic cost of drug abuse treatment: The Drug Abuse Treatment Cost Analysis Program (DATCAP) Journal of Substance Abuse Treatment 14 1997 1 11
20. M.T. French, J.A. Mauskopf, J.L. Teague, and J. Roland Estimating the dollar value of health outcomes from drug abuse interventions Medical Care 34 1996 890 910
21. M.T. French, M.C. Roebuck, and P.K. Alexandre To test or not to test: Do workplace drug testing programs discourage employee drug use? Social Services Research 33 2004 45 63
22. M.T. French, M.C. Roebuck, M.L. Dennis, S.H. Godley, H. Liddle, and F.M. Tims Outpatient marijuana treatment for adolescents: Economic evaluation of a multisite field experiment Evaluation Review 27 2003 421 459
23. M.T. French, M.C. Roebuck, and A.T. McLellan Cost estimation when time and resources are limited: The brief DATCAP Journal of Substance Abuse Treatment 27 2004 187 193
24. M.T. French, M.C. Roebuck, A.T. McLellan, and J.L. Sindelar Can the treatment services review be used to estimate the costs of addiction and ancillary services? Journal of Substance Abuse 12 2000 341 361
25. M.T. French, H.J. Salomé, and M. Carney Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the state of Washington Social Science & Medicine 55 2002 2267 2282
26. M.T. French, H.J. Salomé, J.L. Sindelar, and A.T. McLellan Benefit-cost analysis of addiction treatment: Methodological guidelines and application using the DATCAP and ASI Health Services Research 37 2002 433 455
27. M. Galanter, D.S. Keller, H. Dermatis, and S. Egelko The impact of managed care on substance abuse treatment: A report of the American Society of Addiction Medicine Journal of Addictive Diseases 19 2000 13 34
28. Garber, A. M. (1999). Advances in cost-effectiveness analysis of health interventions. National Bureau of Economic Research, Working Paper 7198.
29. N. Graves, D. Walker, R. Raine, A. Hutchings, and J.A. Roberts Cost data for individual patients included in clinical studies: No amount of statistical analysis can compensate for inadequate costing methods Health Economics 11 2002 735 739
30. J.D. Griffith, M.L. Hiller, K. Knight, and D.D. Simpson A cost-effectiveness analysis of in-prison therapeutic community treatment and risk classification Prison Journal 79 1999 352 368
31. J. Guydish, E. Wolfe, B. Tajima, and W.J. Woods Drug court effectiveness: A review of California evaluation reports, 1995-1999 Journal of Psychoactive Drugs 33 2001 369 378
32. C. Hicks A decade of drug courts Spectrum 72 1999 21
33. D. Hodgkin, C.M. Horgan, D.W. Garnick, and E.L. Merrick Cost sharing for substance abuse and mental health services in managed care plans Medical Care Research and Review 60 2003 101 116
34. R. Hughey, and L.W. Klemke Evaluation of a jail-based substance abuse treatment program Federal Probation 60 1996 40 45
35. K. Jacobsen, and T.G. McGuire Federal block grants and state spending: The alcohol, drug abuse, and mental health block grant and state agency behavior Journal of Health Politics Policy and Law 21 1996 753 770
36. D. Kenkel On valuing morbidity, cost-effectiveness analysis, and being rude Journal of Health Economics 16 1997 749 757
37. F.M. Kunz, M.T. French, and S. Bazargan-Hejazi Cost-effectiveness analysis of a brief intervention delivered to problem drinkers presenting at an inner-city hospital emergency department Journal of Studies on Alcohol 65 2004 363 370
38. S. Lamb, M.R. Greenlick, and D. McCarty Bridging the gap between practice and research: Forging partnerships with community-based drug and alcohol treatment 1998 National Academy Press Washington, DC
39. C.G. Leukefeld, T.K. Logan, S.S. Martin, R.T. Purvis, and D. Farabee A health services use framework for drug-abusing offenders American Behavioral Scientist 41 1998 1123 1136
40. T.K. Logan, W. Hoyt, K.E. McCollister, M.T. French, C. Leukefeld, and L. Minton Economic evaluation of drug court: Methodology, results, and policy implications Evaluation and Program Planning 27 2004 381 396
41. A. Manca, N. Rice, M.J. Sculpher, and A.H. Briggs Assessing generalisability by location in trial-based cost-effectiveness analysis: The use of multilevel models Health Economics 13 2004 1 16
42. P. Marinelli-Casey, C.P. Domier, and R.A. Rawson The gap between research and practice in substance abuse treatment Psychiatric Services 53 2002 984 987
43. K.E. McCollister, and M.T. French The relative contribution of outcome domains in the total economic benefit of addiction interventions: A review of first findings Addiction 98 2003 1647 1659
44. K.E. McCollister, M.T. French, J.A. Inciardi, C.A. Butzin, S.S. Martin, and R.M. Hooper Post-release substance abuse treatment for criminal offenders: A cost-effectiveness analysis Journal of Quantitative Criminology 19 2003 389 407
45. K.E. McCollister, M.T. French, M. Prendergast, E. Hall, and S. Sacks Long-term cost-effectiveness of addiction treatment for criminal offenders: Evaluating treatment history and reincarceration five years post-parole Justice Quarterly 21 2004 659 680
46. K.E. McCollister, M.T. French, M. Prendergast, H. Wexler, S. Sacks, and E. Hall Is in-prison treatment enough? A cost-effectiveness analysis of prison-based treatment and aftercare services for substance-abusing offenders Law and Policy 25 2003 63 82
47. T.R. Miller, M.A. Cohen, and B. Wiersema Victim costs and consequences: A new look 1996 National Institute of Justice Research Report. Department of Justice Washington, DC
48. National Institute on Drug Abuse Report of the Blue Ribbon Task Force on Health Services Research at the National Institute on Drug Abuse 2004 National Institutes of Health, U.S. Department of Health and Human Services Washington, DC
49. J. Oggins Changes in health insurance and payment for substance use treatment American Journal of Drug and Alcohol Abuse 29 2003 55 74
50. T. Olmstead, W.D. White, and J. Sindelar The impact of managed care on substance abuse treatment services Health Services Research 39 2004 319 343
51. J.A. Olsen, and R. Smith Theory vs. practice: A review of willingness to pay in health and health care Health Economics 10 2001 38 52
52. S. Palmer, M. Sculpher, Z. Philips, L. Ginnelly, and A. Bakhai Management of non-ST-elevation acute coronary syndromes: How cost-effective are glycoprotein IIb/IIIa antagonists in the UK National Health Service? International Journal of Cardiology 100 2 2005 229 240
53. S. Parthasarathy, J. Mertens, C. Moore, and C. Weisner Utilization and cost impact of integrating substance abuse treatment and primary care Medical Care 41 2003 357 367
54. S. Parthasarathy, C. Weisner, T. Hu, and C. Moore Association of outpatient alcohol and drug treatment with health care utilization and cost: Revisiting the offset hypothesis Journal of Studies on Alcohol 62 2001 89 97
55. R.H. Peters, and M.R. Murrin Effectiveness of treatment-based drug courts in reducing criminal recidivism Criminal Justice and Behavior 27 2000 72 96
56. C.E. Phelps Health economics 3rd ed. 2003 Addison-Wesley Co. Reading, MA
57. A.S. Rajkumar, and M.T. French Drug use, crime costs, and the economic benefits of treatment Journal of Quantitative Criminology 13 1997 291 323
58. G. Richardson, and A. Manca Calculation of quality adjusted life years in the published literature: A review of methodology and transparency Health Economics 13 2004 1203 1210
59. J.H. Rodgers, and P.G. Barnett Two separate tracks? A multivariate analysis of differences between public and private substance abuse treatment programs American Journal of Drug and Alcohol Abuse 26 2000 429 442
60. M.C. Roebuck, M.T. French, and A.T. McLellan DATStats: Summary results from 85 completed Drug Abuse Treatment Cost Analysis Programs (DATCAPs) Journal of Substance Abuse Treatment 25 2003 51 57
61. M. Ryan, and K. Gerard Using discrete choice experiment to value health care programmes: Current practice and future research reflections Applied Health Economics and Health Policy 2 2003 55 64
62. H.J. Salomé, M.T. French, M. Miller, and A.T. McLellan Estimating the client costs of addiction treatment: First findings from the client DATCAP Drug and Alcohol Dependence 71 2003 195 206
63. M. Schoenbaum, W.Y. Zhang, and R. Sturm Costs and utilization of substance abuse care in a privately insured population under managed care Psychiatric Service 49 1998 1573 1578
64. S.K. Schoenwald, D.M. Ward, S.W. Henggeler, S.G. Pickrel, and H. Patel MST treatment of substance abusing or dependent adolescent offenders: Costs of reducing incarceration, inpatient, and residential placement Journal of Child and Family Studies 5 1996 431 444
65. J.L. Sindelar, M. Jofre-Bonet, M.T. French, and A.T. McLellan Cost-effectiveness analysis of treatments for illicit drug dependence: Paradoxes with multivariate outcomes Drug and Alcohol Dependence 73 2004 41 50
66. The Lewin Group Cost effectiveness and cost benefit analysis of substance abuse treatment: A literature review. National Evaluation Data Services (NEDS) 2002 Harwood, H.J., Malhotra, D., Villarivera, C., Liu, C., Chong, U., & Gilani, J. Falls Church, VA
67. C. Weisner, H. Matzger, T. Tam, and L. Schmidt Who goes to alcohol and drug treatment? Understanding utilization within the context of insurance Journal of Studies on Alcohol 63 2002 673 682
68. C. Weisner, D. McCarty, and L. Schmidt New directions in alcohol and drug treatment under managed care American Journal of Managed Care 5 1999 SP57 SP69
69. C. Weisner, J. Mertens, S. Parthasarathy, C. Moore, E.M. Hunkeler, and T.W. Hue The outcome and cost of alcohol and drug treatment in an HMO: Day hospital versus traditional outpatient regimens Health Services Research 35 2000 791 812
70. J.R.C. Wheeler, H. Fadel, and T.A. D'Aunno Ownership and performance of outpatient substance-abuse treatment centers American Journal of Public Health 82 1992 711 718
71. A.H. Williams Intergenerational equity: An exploration of the 'fair innings' argument Health Economics 6 1997 117 132
72. S.E. Wutzke, A. Shiell, M.K. Gomel, and K.M. Conigrave Cost effectiveness of brief interventions for reducing alcohol consumption Social Science & Medicine 52 2001 863 870
73. G.S. Zaric, P.G. Barnett, and M.L. Brandeau HIV transmission and the cost-effectiveness of methadone treatment American Journal of Public Health 90 2000 1100 1111
74. G.A. Zarkin, J.W. Bray, K.L. Davis, T.F. Babor, and J.C. Higgins-Biddle The costs of screening and brief intervention for risky alcohol use Journal of Studies on Alcohol 64 2003 849 857
75. G.A. Zarkin, J.W. Bray, and J.F. Qi The effect of employee assistance programs use on healthcare utilization Health Services Research 35 2000 77 100
76. G.A. Zarkin, S.C. Cates, and M.V. Bala Estimating the willingness to pay for drug abuse treatment: A pilot study Journal of Substance Abuse Treatment 18 2000 149 159
77. G.A. Zarkin, L.J. Dunlap, and G. Homsi The Substance Abuse Services Cost Analysis Program (SASCAP): A new method for estimating drug treatment services costs Evaluation and Program Planning 27 2004 35 43